Keith Orford

Keith Orford, listed as senior executive, appears in our data through filings on Calithera Biosciences, Inc. shares, published by SEC (Form 4). We count 18 filings; the first trade dates from 17 July 2017 and the latest from 11 November 2021.

Sales make up the whole of the open-market record (14 sales, €207k). Besides market trades, the filings include 4 share grants. So far in 2021, the count stands at no purchases and 3 sales.

The latest filing, published on 12 November 2021, reports an open-market sale of €37k in Calithera Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.